Off Patent
February 2027

Colazal

balsalazide disodium

Valeant Pharmaceuticals International

Capsule (oral) · NDA 020610

Last listed protection ends
February 24, 2027

The FDA lists 2 patents for Colazal, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Ended
    Patent 7,452,872
    Claims a use (U-141)
  2. Ended
    Patent 7,625,884
    Claims a use (U-141)
  3. Patent 7,452,872
    Pediatric extension: six more months
  4. Patent 7,625,884
    Pediatric extension: six more months